0 01/04/2023 31/03/2024 2024-03-31 false false false false false false false true false false true false false false false false true false No description of principal activities is disclosed 2023-04-01 Sage Accounts Production 23.0 - FRS102_2023 xbrli:pure xbrli:shares iso4217:GBP 08749919 2023-04-01 2024-03-31 08749919 2024-03-31 08749919 2023-03-31 08749919 2022-04-01 2023-03-31 08749919 2023-03-31 08749919 2022-03-31 08749919 bus:Director1 2023-04-01 2024-03-31 08749919 core:WithinOneYear 2024-03-31 08749919 core:WithinOneYear 2023-03-31 08749919 core:RetainedEarningsAccumulatedLosses 2024-03-31 08749919 core:RetainedEarningsAccumulatedLosses 2023-03-31 08749919 bus:SmallEntities 2023-04-01 2024-03-31 08749919 bus:AuditExempt-NoAccountantsReport 2023-04-01 2024-03-31 08749919 bus:SmallCompaniesRegimeForAccounts 2023-04-01 2024-03-31 08749919 bus:CompanyLimitedByGuarantee 2023-04-01 2024-03-31 08749919 bus:FullAccounts 2023-04-01 2024-03-31
Company registration number: 08749919
The Genomic Medicine Foundation (UK) Ltd
Company limited by guarantee
Unaudited filleted financial statements
31 March 2024
The Genomic Medicine Foundation (UK) Ltd
Company limited by guarantee
Contents
Balance sheet
Notes to the financial statements
The Genomic Medicine Foundation (UK) Ltd
Company limited by guarantee
Balance sheet
31 March 2024
2024 2023
Note £ £ £ £
Current assets
Debtors 6 10,369 15,889
Cash at bank and in hand 18,954 17,806
_______ _______
29,323 33,695
Creditors: amounts falling due
within one year 7 ( 450) ( 990)
_______ _______
Net current assets 28,873 32,705
_______ _______
Total assets less current liabilities 28,873 32,705
_______ _______
Net assets 28,873 32,705
_______ _______
Capital and reserves
Profit and loss account 28,873 32,705
_______ _______
Members funds 28,873 32,705
_______ _______
For the year ending 31 March 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
Directors responsibilities:
- The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476;
- The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of financial statements.
These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with Section 1A of FRS 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland'.
In accordance with section 444 of the Companies Act 2006, the Profit and loss has not been delivered.
These financial statements were approved by the board of directors and authorised for issue on 13 March 2025 , and are signed on behalf of the board by:
.........................................
Prof Dhavendra Kumar
Director
Company registration number: 08749919
The Genomic Medicine Foundation (UK) Ltd
Company limited by guarantee
Notes to the financial statements
Year ended 31 March 2024
1. General information
The company is a private company limited by guarantee, registered in United Kingdom. The address of the registered office is Eliseg House, Druidstone Road, Old St Mellons, Cardiff, CF3 6XD.
2. Statement of compliance
These financial statements have been prepared in compliance with the provisions of FRS 102, Section 1A, 'The Financial Reporting Standard applicable in the UK and Republic of Ireland'.
3. Accounting policies
Basis of preparation
The financial statements have been prepared on the historical cost basis, as modified by the revaluation of certain financial assets and liabilities and investment properties measured at fair value through profit or loss.
The financial statements are prepared in sterling, which is the functional currency of the entity.
Turnover
Turnover comprises the company's total income in pursuit of is objects from all sources, other than investments in the year.
Financial instruments
A financial asset or a financial liability is recognised only when the entity becomes a party to the contractual provisions of the instrument. All of the financial instruments applying to the company are basic as defied in the Accounting Standard, and as such are initially recognised at the transaction price. Debt instruments are subsequently measured at amortised cost.
4. Limited by guarantee
The organisation is a company limited by guarantee, and as such does not have a share capital. Each member's liabilily is limited to an amount not exceeding £1.
5. Employee numbers
The average number of persons employed by the company during the year amounted to Nil (2023: Nil).
6. Debtors
2024 2023
£ £
Other debtors 10,369 15,889
_______ _______
7. Creditors: amounts falling due within one year
2024 2023
£ £
Other creditors 450 990
_______ _______